Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Epilepsy × Sirolimus × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 17 Lymphoma, Non-Hodgkin 15 Leukemia, Lymphocytic, Chronic, B-Cell 14 Hodgkin Disease 14 Lymphoma, Mantle-Cell 11 Leukemia 11 Sarcoma 10 Multiple Myeloma 10 Lymphoma, Large B-Cell, Diffuse 10 Graft vs Host Disease 10 Lymphoma 9 Burkitt Lymphoma 9 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Congenital Abnormalities 7 Waldenstrom Macroglobulinemia 6 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Accelerated Phase 6 Hematologic Neoplasms 6 Osteosarcoma 5 Neoplasms 5 Leukemia, Prolymphocytic 5

Interventions

Everolimus 2 Sirolimus 1 Medical Marijuana 1 Immunoglobulins, Intravenous 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05104983 2026-01-22

TSC-STEPS

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting

Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡